Claudius Sokenu serves as Executive Vice President and Chief Legal and Compliance Officer at Avantor Inc., a leading global provider of mission-critical products and services to customers in biopharma, healthcare, education, and industrial sectors. In this role, he oversees the company's worldwide legal, compliance, intellectual property, and regulatory functions, ensuring robust governance amid complex international regulations. Sokenu advises Avantor's executive leadership and Board of Directors on strategic initiatives, mergers and acquisitions, and risk management, playing a key part in the company's growth following its 2021 public listing on the New York Stock Exchange. With more than 25 years of legal experience in the life sciences and chemicals industries, Sokenu's career trajectory includes pivotal roles at global organizations. Prior to joining Avantor in 2020, he was Vice President and Deputy General Counsel at DuPont, where he led legal support for the nutrition and biosciences business, managing high-stakes transactions such as the $4.4 billion sale of DuPont's nutritionals business to Royal DSM. Earlier positions at DuPont de Nemours and PepsiCo sharpened his expertise in corporate transactions, antitrust matters, and compliance program development, earning him recognition for mitigating regulatory risks and fostering ethical business practices. Under Sokenu's leadership at Avantor, the company has strengthened its compliance infrastructure, integrated post-merger legal frameworks from the 2020 VWR acquisition, and navigated evolving global regulations like GDPR and U.S. export controls. His strategic foresight has supported Avantor's expansion into high-growth markets, reduced litigation exposures, and promoted a culture of integrity, contributing to the firm's sustained leadership in the scientific services sector.